$JAZZ Jazz Pharmaceuticals plc Insider Trading
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Jazz Pharmaceuticals plc. Insider overview, share value development, latest insider transactions and email notifications about new events in Jazz Pharmaceuticals plc for free.
CIK Number: 0001232524
IRS Number: 981032470
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: JAZZ
Company Address: FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN 4
Phone number: 650-496-3777
Former name: JAZZ PHARMACEUTICALS INC, date of change: 2003-05-13
Market Capitalization: $7.62B
Prev close: $125.05
Average Daily Volume: 655,379
Days Low: $124.77
Year Low: $95.80
Year High: $160.00
Jazz Pharmaceuticals plc Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | JAZZ | Jazz Pharmaceutica ... | Tovey Christopher J. | EVP COO & Managing ... | Grant | A | 0.00 | 9,091 | 0 | 9,116 | 25 to 9.1 K (+36,364.00 %) |
May 07 2021 | JAZZ | Jazz Pharmaceutica ... | Tovey Christopher J. | EVP COO & Managing ... | Grant | A | 0.00 | 9,091 | 0 | 9,116 | 25 to 9.1 K (+36,364.00 %) |
May 05 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 170.00 | 500 | 85,000 | 321,341 | 321.8 K to 321.3 K (-0.16 %) |
May 05 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 164.24 | 1,500 | 246,360 | 321,841 | 323.3 K to 321.8 K (-0.46 %) |
Apr 07 2021 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Payment of Exercise | F | 164.71 | 1,515 | 249,536 | 25,347 | 26.9 K to 25.3 K (-5.64 %) |
Apr 06 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 164.96 | 1,500 | 247,440 | 323,341 | 324.8 K to 323.3 K (-0.46 %) |
Mar 10 2021 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Sell | S | 161.60 | 1,509 | 243,859 | 16,519 | 18 K to 16.5 K (-8.37 %) |
Mar 10 2021 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 161.50 | 961 | 155,202 | 6,045 | 7 K to 6 K (-13.72 %) |
Mar 10 2021 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 161.61 | 1,089 | 175,988 | 7,006 | 8.1 K to 7 K (-13.45 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Payment of Exercise | F | 164.75 | 3,718 | 612,541 | 49,961 | 53.7 K to 50 K (-6.93 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Pearce Samantha | SVP, Head of Europ ... | Payment of Exercise | F | 164.75 | 1,402 | 230,980 | 11,958 | 13.4 K to 12 K (-10.49 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Payment of Exercise | F | 164.75 | 691 | 113,842 | 26,147 | 26.8 K to 26.1 K (-2.57 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP R&D, Chief Medi ... | Payment of Exercise | F | 164.75 | 741 | 122,080 | 30,145 | 30.9 K to 30.1 K (-2.40 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 164.75 | 21,516 | 3,544,761 | 324,841 | 346.4 K to 324.8 K (-6.21 %) |
Mar 03 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 170.00 | 9,600 | 1,632,000 | 346,357 | 356 K to 346.4 K (-2.70 %) |